Scarica l'app Stockscreener
101.10
0.35%
0.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Incyte Corp Borsa (INCY) Ultime notizie
Incyte’s weak Opzelura 2026 revenue forecast heightens Jakafi patent concerns (Feb 10) By Reuters - Investing.com
Is It Too Late To Consider Incyte (INCY) After Its 43% One Year Rally - Yahoo Finance
Incyte Corporation $INCY Shares Sold by Sound Shore Management Inc CT - MarketBeat
LSV Asset Management Buys 124,266 Shares of Incyte Corporation $INCY - MarketBeat
Illinois Municipal Retirement Fund Sells 15,073 Shares of Incyte Corporation $INCY - MarketBeat
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
INCY: Stifel Raises Price Target to $120, Maintains Buy Rating | - GuruFocus
Incyte shifts course on downtown Wilmington project, sells Bracebridge buildings as state incentives face scrutiny - Delaware LIVE News
Incyte selling buildings and cutting back space at future downtown headquarters - Delaware Business Now
Incyte selling buildings and cut back space at future downtown headquarters - Delaware Business Now
Royal Bank Of Canada Cuts Incyte (NASDAQ:INCY) Price Target to $92.00 - MarketBeat
Incyte (INCY): RBC Capital Lowers Price Target to USD 92 | INCY Stock News - GuruFocus
Incyte (INCY) Analyst Ratings Update: Wells Fargo Lowers Price Target | INCY Stock News - GuruFocus
Wells Fargo & Company Cuts Incyte (NASDAQ:INCY) Price Target to $101.00 - MarketBeat
INCY Q4 Deep Dive: Revenue Growth Outpaces Profit as Pipeline Advances, Margins Narrow - Finviz
Incyte Corporation (NASDAQ:INCY) Q4 2025 Earnings Call Transcript - Insider Monkey
INCY: HC Wainwright & Co. Reiterates Buy Rating, Maintains $135 Price Target | INCY Stock News - GuruFocus
Incyte Faces Growing Pains As It Looks To Build Post-Jakafi Foundation - Citeline News & Insights
Incyte Shares Surge on Strong Revenue Performance and Pipeline Progress - AD HOC NEWS
Incyte Faces Jakafi Patent Cliff; Focus on Opzelura and Advancing Pipeline to Offset Losses - Morningstar
Decoding Incyte Corp (INCY): A Strategic SWOT Insight - GuruFocus
Incyte: Fourth Quarter Earnings Overview - Bitget
Incyte (INCY) Shares Fall After Q4 Earnings Miss and Weak 2026 O - GuruFocus
Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance - AlphaStreet News
Incyte Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Incyte (INCY) Reports Strong Q4 and Annual Revenue Growth - GuruFocus
Incyte Q4 Earnings Call Highlights - Yahoo Finance
Incyte Corp (INCY) Q4 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Incyte (INCY) Shares Fall After Q4 Earnings Miss and Weak 2026 Outlook - GuruFocus
Jefferies reiterates Buy rating on Incyte stock, maintains $120 price target - Investing.com Canada
Why Incyte (INCY) Stock Is Nosediving - Finviz
INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales - sharewise.com
Incyte (INCY) Releases Product Revenue and Expense Guidance for 2026 - GuruFocus
Incyte (NASDAQ:INCY) Shares Gap Down Following Weak Earnings - MarketBeat
Truist Securities reiterates Hold rating on Incyte stock, maintains $103 target - Investing.com
Incyte Q4 2025 slides: Revenue surges 28%, stock dips on EPS miss - Investing.com
Incyte (INCY) Q4 2025 Earnings Call Transcript - The Globe and Mail
Incyte (INCY) Faces Challenges with Opzelura as Jakafi Patent Expiry Looms - GuruFocus
Earnings call transcript: Incyte’s Q4 2025 revenue beats estimates, stock dips - Investing.com
Incyte (INCY) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Incyte (NASDAQ:INCY) Posts Quarterly Earnings Results, Misses Estimates By $0.16 EPS - MarketBeat
Incyte (NASDAQ:INCY) Surprises With Q4 CY2025 Sales - Finviz
Incyte (INCY) Reports Strong Q4 Revenue and Promising Pipeline G - GuruFocus
Incyte Corp. (NASDAQ:INCY) Reports Mixed Q4 2025 Results with Revenue Beat and EPS Miss - ChartMill
Incyte (INCY) Q4 Earnings Lag Estimates - Yahoo Finance
Incyte weak 2026 revenue forecast heightens Jakafi patent concerns - Reuters
Incyte: Q4 Earnings Snapshot - kens5.com
Incyte (INCY) Q4 Revenue Surpasses Estimates Despite EPS Miss - GuruFocus
Incyte shares fall as Q4 earnings miss overshadows revenue beat - Investing.com
Incyte shares fall as Q4 earnings miss overshadows revenue beat By Investing.com - Investing.com South Africa
Incyte earnings missed by $0.11, revenue topped estimates - Investing.com
Incyte earnings missed by $0.11, revenue topped estimates By Investing.com - Investing.com South Africa
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Earnings Breakdown: Incyte Q4 - Benzinga
Why Incyte (NASDAQ:INCY) Appears in Nasdaq Composite Index Coverage? - Kalkine Media
A Look Ahead: Incyte's Earnings Forecast - Benzinga
Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? - Yahoo Finance
Incyte earnings up next: Can pipeline ease Jakafi reliance? - Investing.com
Incyte earnings up next: Can pipeline ease Jakafi reliance? By Investing.com - Investing.com UK
Here's Why Incyte (INCY) is a Strong Value Stock - Yahoo Finance
Incyte (INCY) Q4 Earnings: What To Expect - Finviz
Thrivent Financial for Lutherans Purchases 39,660 Shares of Incyte Corporation $INCY - MarketBeat
Piper Sandler Raises Incyte (INCY) Price Target to $110 | INCY S - GuruFocus
Incyte sets February 10 call to unveil Q4 and full-year 2025 results - MSN
0.87%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):